A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Clinical trial NCT01254630 · COMPLETED
Trial details
- NCT number
- NCT01254630
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-24
- Primary completion
- 2017-04-11
- Enrollment
- 5305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.